^Shannon HE (April 1983). "Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat". The Journal of Pharmacology and Experimental Therapeutics. 225 (1): 144–52. PMID6834266.
^He XS, Bowen WD, Lee KS, Williams W, Weinberger DR, de Costa BR (March 1993). "Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites". Journal of Medicinal Chemistry. 36 (5): 566–71. doi:10.1021/jm00057a006. PMID8496936.